Serotype | PHiD-CV | PCV13 | References |
---|---|---|---|
All-cause pneumonia | |||
 Inpatient | 23.4% | 23.7% | [11] |
 Outpatient | 7.3% | 7.3% (assumed to be the same as PHiD-CV) | [11] |
IPD | |||
 VT (10 common ST) | 94.7% | 94.7% | [28] |
 3 | 0% | 0% | |
 6A | 76.0% (assumed to be the same as PCV7) | 94.7% (VT) | [28] |
 19A | 71% (base case) 19% (used in scenario analysis: worst case using Taiwan point estimate of PCV7/10) | 80% | |
AOM | |||
 AOM VT VE 10 common serotypes | 69.9% | 69.9% | [11] |
 ST3 AOM VE | 0% [10] | 0% | [11] |
 6A AOM VE | 29.0% | 69.9% | [11] |
 19A | 29.0% | 69.9% | [11] |
 NVT AOM VE | −33% | −33% | [35] |
 NTHi AOM VE | 21.5% [11] [0–35.3% in sensitivity analysis] | 0% (based on expert opinion) [−11 to + 8% in sensitivity analysis] | |
 AOM Myringotomy | 38.82% | 30.6% | Estimated based on [37, 38] and overall AOM efficacies above |